|
000
| 01619cam 2200373zi 4500 |
|---|
| 001 | 9.947239 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250312091237 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 250122e20250224onc ob f000 0 eng d |
|---|
| 020 | |a9780660753638 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-359/2025E-PDF |
|---|
| 245 | 00|aSubmitting risk management plans guidance document. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cFebruary 24, 2025. |
|---|
| 264 | 4|c©2025 |
|---|
| 300 | |a1 online resource (iv, 39 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice sur la présentation des plans de gestion des risques. |
|---|
| 500 | |a"Date issued: February 24, 2025. Effective date: July 1, 2025." |
|---|
| 500 | |a"Pub.: 240794." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aPharmaceutical industry|xRisk management|zCanada. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice sur la présentation des plans de gestion des risques.|w(CaOODSP)9.947240 |
|---|
| 856 | 40|qPDF|s812 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-359-2025-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/guidance-submission-risk-management-plans-policy-overview.html |
|---|